Pittsburgh International Lung Conference
October 9-10, 2009
Pictures from this year's conference!
This exceptional two-day conference provides a forum for clinicians on the frontlines of treating patients with pulmonary vascular disease and researchers interested in advancing our understanding of pulmonary vascular biology.
Registration for the conference is free of charge.
Clinical Applications
The agenda for the first day focuses on clinical updates in pulmonary diseases, including an emphasis on Pulmonary Hypertension. The program is an excellent opportunity for physicians who are interested in learning about the latest developments in pulmonary medicine, and specifically in pulmonary hypertension.
The morning sessions of the first day will cover updates in broad areas of pulmonary disease, presented by national leaders in pulmonary medicine. The distinguished speakers include:
- Frank A. Bontempo, MD | University of Pittsburgh
- Michael P. Donahoe, MD | University of Pittsburgh
- Kevin F. Gibson, MD | University of Pittsburgh
- Alison Morris, MD, MS | University of Pittsburgh
- John J. Reilly, Jr., MD | University of Pittsburgh
- Frank C. Sciurba, MD | University of Pittsburgh
- Sally E. Wenzel, MD | University of Pittsburgh
The afternoon of day one will feature a clinical spotlight on Pulmonary Hypertension Diagnosis and Management, presented by national leaders in Pulmonary Hypertension, including:
- Hunter C. Champion, MD, PhD | University of Pittsburgh
- Roberto F. P. Machado, MD | University of Chicago
- Michael A. Mathier, MD | University of Pittsburgh
Following all speaker sessions, there will be a poster reception for researchers to present original research. The day will conclude with an evening banquet featuring Lewis J. Rubin, MD from the University of California, San Diego, who will discuss the future of multi-drug therapy for pulmonary hypertension.
Research Developments
The second day of the conference will focus on translational research in pulmonary vascular disease presented by leaders in the field, including:
- Steven L. Archer, MD | University of Chicago
- Augustine M. K. Choi, MD | Harvard University
- Raed A. Dweik, MD | The Cleveland Clinic
- Bruce A. Freeman, PhD | University of Pittsburgh
- C. Michael Hart, MD | Emory University
- James E. Loyd, MD | Vanderbilt University
- Marlene Rabinovitch, MD | Stanford University
- Pravin B. Sehgal, MD, PhD | New York Medical College
- Kurt R. Stenmark, MD | University of Colorado, Denver
- Rubin M. Tuder, MD | University of Colorado, Denver
- Jason X.-J. Yuan, MD, PhD | University of California, San Diego
Scientific Sessions:
- Clinical Masters: Update on Obstructive Lung Disease
- Clinical Masters: Update on ILD, PE, Sleep Apnea and ARDS
- Clinical Spot Light on: Pulmonary Hypertension
- Pulmonary Hypertension: Novel Small Molecule Therapeutics
- New Mechanisms of Pulmonary Vascular Disease
- Dysregulation of Nitric Oxide, Reactive Oxygen Species, and Hydrogen Sulfide in Pulmonary Hypertension Vasculopathy
- Genetics, Structure and Function in Pulmonary Hypertension
